American Brain Foundation
Ben LeNail is an experienced professional currently serving as a Commercial Advisor at Flow Neuroscience and CIONIC, as well as Vice Chair for the American Brain Foundation and an Advisor at UCSF Center for Vulnerable Populations. Ben LeNail is also involved with the Chan Zuckerberg Initiative as a mentor for the Rare as One Project and is a member of the Screening Committee at HealthTech Capital, where investments include over 30 medical startups. As a co-founder and board member of ALD Connect, Ben LeNail contributes to research on X-linked adrenoleukodystrophy and has previously provided services as a literacy tutor and advisor at Autobahn Therapeutics and Deep Genomics. Educational qualifications include an Executive MBA from INSEAD, an MBA from the University of Washington, and a BA from Sciences Po, complemented by various executive and continuing studies at Stanford University.
This person is not in any teams
This person is not in any offices
American Brain Foundation
Since 1992, the American Brain Foundation has been investing in research to end the battle against brain diseases and disorders. We are a national foundation in relentless pursuit to identify causes, improve treatments, and discover cures. We unite donors and researchers to impact patient lives and those around them. We invest in research of the whole brain and all nervous system disorders knowing they are interconnected. This holistic, innovative approach allows us to build bridges between diseases and break new ground in research and application. Believing in a whole-brain approach gives us an edge in understanding and combating brain disease. We understand that when we cure one of them, we will cure many. Learn more by visiting www.AmericanBrainFoundation.org. Mission: The American Brain Foundation brings researchers and donors together to cure brain diseases and disorders. Vision: Life without brain disease.